Literature DB >> 8725860

Risk factors predicting lower extremity amputations in patients with NIDDM.

S Lehto1, T Rönnemaa, K Pyörälä, M Laakso.   

Abstract

OBJECTIVE: To examine the predictors of lower extremity amputation in patients with NIDDM. RESEARCH DESIGN AND METHODS: At baseline, risk factors for amputation were determined in 1,044 NIDDM patients (571 men, 473 women) aged 45 to 64 years. These patients were followed up to 7 years with respect to amputation.
RESULTS: The incidence of amputation was 5.6% in men and 5.3% in women. High fasting plasma glucose at baseline examination and the duration of diabetes were associated with a twofold risk for amputation. Similarly, glycemic control measured at baseline by HbA1 was an important predictor of amputation. There was a dose-response relationship between plasma glucose or HbA1 and the risk for amputation. The effect of hyperglycemia on the risk of amputation was seen clearly even after the adjustment for other cardiovascular risk factors. Signs of peripheral neuropathy and bilateral absence of Achilles tendon reflexes and vibration sense were important predictors for amputation. Furthermore, absent peripheral artery pulses and femoral artery bruit on auscultation predicted amputation.
CONCLUSIONS: Our 7-year follow-up study gives strong evidence that poor glycemic control is an important predictor of amputation in patients with NIDDM in addition to clinically detectable peripheral arterial disease and peripheral neuropathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725860     DOI: 10.2337/diacare.19.6.607

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  34 in total

Review 1.  The HbA1c and all-cause mortality relationship in patients with type 2 diabetes is J-shaped: a meta-analysis of observational studies.

Authors:  Luke W Arnold; Zhiqiang Wang
Journal:  Rev Diabet Stud       Date:  2014-08-10

2.  The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration.

Authors:  Suzan Tabur; Mehmet Ali Eren; Yakup Çelik; Omer Faruk Dağ; Tevfik Sabuncu; Zeynel Abidin Sayiner; Esen Savas
Journal:  Wien Klin Wochenschr       Date:  2014-11-15       Impact factor: 1.704

3.  Initial nontraumatic lower-extremity amputations among veterans with diabetes.

Authors:  Usha Sambamoorthi; Chin-Lin Tseng; Mangala Rajan; Tiwari Anjali; Patricia A Findley; Leonard Pogach
Journal:  Med Care       Date:  2006-08       Impact factor: 2.983

4.  Laterality of lower limb amputation in diabetic patients: retrospective audit.

Authors:  J P Coxon; I W Gallen
Journal:  BMJ       Date:  1999-02-06

5.  Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study.

Authors:  Björn Rathsman; Kerstin Jensen-Urstad; Thomas Nyström
Journal:  Diabetologia       Date:  2014-05-07       Impact factor: 10.122

Review 6.  Diabetes: foot ulcers and amputations.

Authors:  Dereck Hunt
Journal:  BMJ Clin Evid       Date:  2009-01-12

Review 7.  Matrix metalloproteinases and peripheral arterial disease.

Authors:  Chiara Busti; Emanuela Falcinelli; Stefania Momi; Paolo Gresele
Journal:  Intern Emerg Med       Date:  2009-07-21       Impact factor: 3.397

8.  Aiming at "de feet" and diabetes: a rural model to increase annual foot examinations.

Authors:  Susie E Beem; Margaret Machala; Craig Holman; Randal Wraalstad; Ann Bybee
Journal:  Am J Public Health       Date:  2004-10       Impact factor: 9.308

9.  Independent risk factors for amputation in diabetic foot.

Authors:  Abolfazl Shojaiefard; Zhamak Khorgami; Bagher Larijani
Journal:  Int J Diabetes Dev Ctries       Date:  2008-04

10.  Implementation of diabetic foot ulcer classification system for research purposes to predict lower extremity amputation.

Authors:  Abubakr H Widatalla; Seif Eidin I Mahadi; Mohamed A Shawer; Hagir A Elsayem; Mohamed E Ahmed
Journal:  Int J Diabetes Dev Ctries       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.